Solid Biosciences (SLDB) Financials

$9.84

$-0.30 (-2.91%)

As on 28-Aug-2026 13:35EDT

Market cap

$997 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	8.09	13.62
Cost of Revenue	1.24	1.64	2.46	2.58	2.41	2.96
Gross Profit	-1.24	-1.64	-2.46	-2.58	8.09	13.62
Operating Expenses	211.76	177.57	127.27	101.73	114.55	85.87
Operating Profit (EBIT)	-212.15	-179.21	-129.73	-104.32	-106.45	-72.25
Other Income	--	--	--	--	20.47	0.07
Profit before Tax	-207.10	-174.33	-124.70	-96.02	-85.98	-72.19
Provision for Tax	--	--	--	--	-20.47	-0.06
Profit after Tax (Net Income)	-207.10	-174.33	-124.70	-96.02	-85.98	-72.19
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-85.98	-72.19

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	374.08	180.01	137.25	126.48	211.67	208.21
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	17.92	19.06	21.16	23.94	26.08	0.57
Current Liabilities	28.58	33.47	30.26	14.52	22.51	23.60
Total Liabilities	449.16	232.54	188.66	164.94	260.25	232.38

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	25.47	27.08	31.36	35.21	40.61	9.77
Current Assets	395.11	205.46	157.30	129.73	219.64	222.61
Total Assets	449.16	232.54	188.66	164.94	260.25	232.38
Total Debt*	20.16	21.16	24.18	26.27	28.55	2.06
Net Current Assets	366.52	171.98	127.05	115.22	197.13	199.01

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-156.29	-100.01	-94.18	-97.98	-77.76
Cash Flow from Investing Activities	--	-58.45	-16.09	9.69	59.16	-91.09
Cash from Financing Activities	--	194.45	122.44	3.12	74.83	134.99
Net Cash Inflow / Outflow	--	--	--	--	36.01	-33.87

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.91	-1.84	-2.33	-3.31	-10.72	-9.64
Cash EPS ($)	--	-1.82	-2.28	-3.21	-10.42	-9.24
Adjusted Book Value ($)	--	1.90	2.56	4.36	26.38	27.81
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.65	-1.87	-3.25	-12.21	-10.39
Free Cash Flow per Share ($)	--	-1.66	-1.88	-3.30	-12.59	-10.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-96.15	-79.38	-48.87	-38.17	-41.55
ROE (%)	-74.75	-109.90	-94.57	-56.79	-40.96	-42.43
ROA (%)	-52.61	-82.78	-70.53	-45.16	-34.91	-35.78
EBIT Margin (%)	--	--	--	--	-1,226.51	-530.01
Net Margin (%)	--	--	--	--	-301.00	-527.46
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.41	3.08
EBIT Growth (%)	-34.66	-40.18	-29.52	3.28	-37.52	18.24
Net Profit Growth (%)	-34.41	-39.80	-29.87	-11.67	-19.11	18.24
EPS Growth (%)	26.49	0.21	0.30	0.69	-0.11	0.49
Book Value Growth (%)	-5.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.06	-1.72	-1.86	-0.50	-0.18
Price / Book Value	2.67	2.97	1.56	1.41	0.20	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.69	-2.13	-0.73	-0.86	1.47	2.78
Close Price ($)	9.99	5.64	4.00	6.14	5.38	26.25
High Price ($)	10.41	7.37	15.05	8.20	27.53	173.70
Low Price ($)	3.79	2.41	3.85	1.81	5.21	23.85
Market Cap ($ Cr)	997.19	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.12	0.18	0.21	0.13	0.01
Short term debt to equity ratio	0.01	0.01	0.02	0.02	0.01	0.01
Current Ratio	13.82	6.14	5.20	8.94	9.76	9.43
Quick Ratio	13.82	--	--	--	--	9.18
Interest Coverage	-615.37	--	-365.76	-218.22	-4.85	-1,093.76

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	0.81
Asset Turnover	--	--	--	--	0.03	0.07
Receivable days	--	--	--	--	2.48	1.47
Inventory Days	--	--	--	--	912.37	741.22
Payable days	--	832.86	466.34	372.89	584.05	476.71
Cash Conversion Cycle	--	--	--	--	330.80	265.99

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.